No Safety issues compared to Std treatment 4 months [clinicaltrials_resource:2707a57f360a2df924ea058f8794a504]
The wound will be treated either with the investigational formulation or the conventional treatment daily for 3 months.. After 15 minutes, the wound will be dressed with a fresh TegadermTM dressing. Monitoring of any adverse events will be performed on a daily basis.
Once a week, the wound will be monitored by a physician: wound size will be determined and documented by photograph. Patients will be evaluated for pain sensation at the wound area and satisfaction by completing a QoL questionnaire Once a month during the experiment and one month after the end of treatment patients will undergo blood profile, blood glucose, and urine samples testing: at the initial and terminating visits. ECG and Ulcer culture will be also carried out. HbA1c, will be monitored once in 4 months
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
No Safety issues compared to Std treatment 4 months [clinicaltrials_resource:2707a57f360a2df924ea058f8794a504]
The wound will be treated either with the investigational formulation or the conventional treatment daily for 3 months.. After 15 minutes, the wound will be dressed with a fresh TegadermTM dressing. Monitoring of any adverse events will be performed on a daily basis.
Once a week, the wound will be monitored by a physician: wound size will be determined and documented by photograph. Patients will be evaluated for pain sensation at the wound area and satisfaction by completing a QoL questionnaire Once a month during the experiment and one month after the end of treatment patients will undergo blood profile, blood glucose, and urine samples testing: at the initial and terminating visits. ECG and Ulcer culture will be also carried out. HbA1c, will be monitored once in 4 months
Bio2RDF identifier
2707a57f360a2df924ea058f8794a504
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2707a57f360a2df924ea058f8794a504
measure [clinicaltrials_vocabulary:measure]
No Safety issues compared to Std treatment
time frame [clinicaltrials_vocabulary:time-frame]
description
The wound will be treated eith ...... be monitored once in 4 months
identifier
clinicaltrials_resource:2707a57f360a2df924ea058f8794a504
title
No Safety issues compared to Std treatment 4 months
@en
type
label
No Safety issues compared to S ...... 7a57f360a2df924ea058f8794a504]
@en